| Today's Top Story |  |  | | | Health Care & Policy | | | | - Navidea enrolls first patient in Phase III trial of NAV4694
Navidea Biopharmaceuticals said it has signed up the first patient in a Phase III trial that will test the PET imaging agent NAV4694. The study will evaluate the safety and efficacy of the agent in identifying beta amyloid in end-of-life patients with and without dementia. The study, to eventually include 275 individuals, will compare imaging data during life with autopsy findings. AuntMinnie.com (free registration) (6/27)       | Company & Financial News | | | | - Onyx rejects rival's $10B takeover offer
Onyx Pharmaceuticals turned down Amgen's roughly $10 billion, or $120-per-share, takeover bid, saying it "significantly undervalued" the firm. Onyx, whose products include thyroid cancer drug Nexavar and colon cancer drug Stivarga, hired a financial adviser to seek potential buyers. Reuters (6/30) | Food & Agriculture | | | | - Kauai County, Hawaii, passes biotech bill, sets public hearing
The Kauai County Council of Hawaii approved in the first reading a bill that would require agricultural firms to disclose the use of pesticides and the presence of biotech crops. The bill, now scheduled for public hearing July 31, would also allow the county to temporarily ban the experimental use and commercial production of biotech crops until an environmental impact statement is completed. The Garden Island (Lihue, Hawaii) (6/28) | Hot Topics | | | | Top five news stories selected by BIO SmartBrief readers in the past week. - Results based on number of times each story was clicked by readers.
| Industrial & Environmental | | | | - Demonstration-scale waste-to-ethanol plant is launched in Spain
Spain's Abengoa has launched its first demonstration-scale facility that can process solid waste into ethanol. The plant, which is in central Spain, has the capacity to produce 396,000 gallons of ethanol from 25,000 tons of municipal solid waste, Abengoa said. According to Bloomberg New Energy Finance, Abengoa's plant is the biggest of its kind in the world. Bloomberg (6/27)  | |  | | The Buzz(CORPORATE ANNOUNCEMENTS)
| |  | |  |
| News from BIO | | | | - Register today for the BIO Investor Forum, Oct. 8-9, in San Francisco
The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and One-on-One partnering meetings. BIO is renowned for its successful business development, partnering and investor meetings in North America, Europe and Asia. Partnering at this conference will be powered by BIO One-on-One Partnering, an interactive environment to intelligently search, contact and schedule private meetings with potential partners and investors. Register today.
| SmartQuote | | | |  | Would that well-thinking people should be replaced by thinking ones."
--Natalie Clifford Barney,
American playwright  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Friday, June 28, 2013
- Thursday, June 27, 2013
- Wednesday, June 26, 2013
- Tuesday, June 25, 2013
- Monday, June 24, 2013
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2013 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment